返回首页
AI on Medium··行业媒体

ByteDance Spun Off Its AI Drug Unit, Then Raised $290 Million at $1.5 Billion

中文摘要

字节跳动将AI制药部门Anew Labs分拆,该公司以15亿美元估值融资2.9亿美元,字节跳动仍持有56%股份。

English Summary

ByteDance spun off its AI drug unit Anew Labs, which raised $290 million at a $1.5 billion valuation; ByteDance retains a 56% stake.

原文节选

Anew Labs closed its first outside round led by HSG, IDG, and Hillhouse. ByteDance keeps a 56% stake. Continue reading on All My Circuits »